Article citationsMore>>
A. Mima, H. Arai, T. Matsubara, H. Abe, K. Nagai, Y. Tamura, K. Torikoshi, M. Araki, H. Kanamori, T. Takahashi, T. Tominaga, M. Matsuura, N. Iehara, A. Fukatsu, T. Kita and T. Doi, “Urinary Smad1 Is a Novel Marker to Predict Later Onset of Mesangial Matrix Expansion in Diabetic Nephropathy,” Diabetes, Vol. 57, No. 6, 2008, pp. 17121722. doi:10.2337/db071726
has been cited by the following article:
-
TITLE:
Therapeutic Modalities in Diabetic Nephropathy: Future Approaches
AUTHORS:
William Brian Reeves, Bishal B. Rawal, Emaad M. Abdel-Rahman, Alaa S. Awad
KEYWORDS:
Markers; Albuminuria; Diabetes; Therapy
JOURNAL NAME:
Open Journal of Nephrology,
Vol.2 No.2,
June
25,
2012
ABSTRACT: Diabetes mellitus is the leading cause of end stage renal disease and is responsible for more than 40% of all cases in the United States. Several therapeutic interventions for the treatment of diabetic nephropathy have been developed and implemented over the past few decades with some degree of success. However, the renal protection provided by these therapeutic modalities is incomplete. More effective approaches are therefore urgently needed. Recently, several novel therapeutic strategies have been explored in treating DN patients including Islet cell transplant, Aldose reductase inhibitors, Sulodexide (GAC), Protein Kinase C (PKC) inhibitors, Connective tissue growth factor (CTGF) inhibitors, Transforming growth factor-beta (TGF-β) inhibitors and bardoxolone. The benefits and risks of these agents are still under investigation. This review aims to summarize the utility of these novel therapeutic approaches.
Related Articles:
-
Liliane Silvano Araújo, Marcos Vinícius da Silva, Crislaine Aparecida da Silva, Maria Luiza Reis Monteiro, Lívia Helena de Morais Pereira, Laura Penna Rocha, Rosana Rosa Miranda Corrêa, Marlene Antônia Reis, Juliana Reis Machado
-
R. Douglas Martin, Shengyu Zhang
-
Mikael Pihl, Mikael Chéramy, Jenny Mjösberg, Johnny Ludvigsson, Rosaura Casas
-
Daoling Fu, Ming Yang, Jindong Chang
-
Mikhail U. Alekseev, Aleksandr M. Alekseev